Curaleaf Holdings (CURLF) Return on Capital Employed (2020 - 2024)
Curaleaf Holdings (CURLF) recorded quarterly Return on Capital Employed of 0.46% in Q4 2024, down 26.21% quarter-over-quarter from 0.62% in Q3 2024, and down 63.0% on a YoY basis from 1.24% in Q1 2024.
Curaleaf Holdings (CURLF) Return on Capital Employed (2020 - 2024) Analysis & Trends
Curaleaf Holdings' Return on Capital Employed history runs 5 years deep, the most recent figure standing at 0.46% for Q4 2024.
- In Q4 2024, Return on Capital Employed fell 63.0% year-over-year to 0.46%; the TTM figure through Dec 2024 stood at 0.46% (down 63.0% YoY), while the FY2025 annual figure was 0.98%, up 4.0% from the prior year.
- Return on Capital Employed was 0.46% for Q4 2024 at Curaleaf Holdings, down from 0.62% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 5.45% in Q3 2021 to a low of 1.94% in Q3 2023.
- Historically, Return on Capital Employed has averaged 2.65% across 5 years, with a median of 3.67% in 2020.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed slumped 651 bps in 2023, then surged 256 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 3.08% in 2020, then surged by 63 bps to 5.01% in 2021, then fell by 9 bps to 4.57% in 2022, then sank by 76 bps to 1.08% in 2023, then sank by 58 bps to 0.46% in 2024.
- The last three Return on Capital Employed figures came in at 0.46% (Q4 2024), 0.62% (Q3 2024), and 1.08% (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 6.92% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 14.85% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -1.92% |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.46% |
| Sep 30, 2024 | 0.62% |
| Dec 31, 2023 | 1.08% |
| Sep 30, 2023 | -1.94% |
| Sep 30, 2022 | 4.57% |
| Jun 30, 2022 | 4.45% |
| Mar 31, 2022 | -0.03% |
| Dec 31, 2021 | 5.01% |
| Sep 30, 2021 | 5.45% |
| Jun 30, 2021 | 4.77% |
| Mar 31, 2021 | 4.25% |
| Dec 31, 2020 | 3.08% |